Data protection Impressum

R&D

The Swiss Deeptech Report 2026 ranks Switzerland first in the world for the share of venture capital flowing to deeptech and first in Europe per capita, with EPFL in Lausanne named among Europe's two leading universities for deeptech spinouts.

Business environment

Switzerland leads the world in deeptech venture funding in 2026

17 June 2026

908 Devices, a US-listed maker of handheld chemical analysis devices, has acquired NIRLAB, a University of Lausanne spin-out developing AI-powered narcotics detection, for an upfront USD 15 million plus up to USD 8 million in performance-based consideration.

US firm 908 Devices acquires Lausanne narcotics-detection start-up NIRLAB

16 June 2026

Edwatec, an EPFL spin-off developing photonic systems for AI infrastructure, won the CHF 150,000 Grand Prize at the venture 2026 awards held at EPFL in Lausanne, where start-ups from across Switzerland, including several from the Lake Geneva region, were honored.

EPFL spin-off Edwatec wins Grand Prize at the venture 2026 awards

16 June 2026

Business environment

The Marly Innovation Center reaches 200 companies and 1,000 jobs in 2026

15 June 2026

Atinary, the Lausanne and Menlo Park-based pioneer in Self-Driving Labs, has been selected as a 2026 Technology Pioneer by the World Economic Forum.

Atinary named a 2026 Technology Pioneer by the World Economic Forum

15 June 2026

Following the strong scientific performance of the CHEOPS space telescope, the European Space Agency has extended its mission until the end of 2029, keeping its science operations center at the University of Geneva at the heart of European exoplanet research.

ESA extends the CHEOPS space telescope mission until 2029

15 June 2026

A new EY study ranks Switzerland 3rd worldwide for corporate R&D intensity and 6th for total spending, with 14 Swiss companies among the global top 500.

Switzerland ranks 3rd globally for corporate R&D intensity

18 May 2026

The Swiss Biotech Report 2026 reveals record sector revenues and a landmark year for private funding, as talent and international collaboration continue to underpin Switzerland's position at the forefront of global life sciences.

Swiss Biotech Report 2026: talent and tenacity drive record performance

5 May 2026

The applied research partnership between CSEM, the Insel Gruppe, and the University of Bern has been extended for three years, building on 32 medtech projects launched since 2023 and reinforcing Bern's ambition to become a leading international medical hub by 2030.

CSEM, Insel Gruppe, and University of Bern extend Bern medtech collaboration for three more years

20 April 2026

ONWARD Medical has secured EUR 40.6 million through an accelerated bookbuild offering led by a EUR 25 million investment from EQT Life Sciences, extending the company's cash runway into the first quarter of 2028.

ONWARD Medical raises EUR 40 million to extend ARC therapy commercialization

20 April 2026

1 2 3 4 5 6 7 … 16